Anticompetitive Abuse of the Orphan Drug Act
Subtitle: invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992.
Series: S. hrg. ;; 102-615
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1992
Place of publication: Washington
Language: eng
Number of pages: 319
Subjects: Orphan drugs -- Law and legislation -- United States.
Notes: Includes bibliographical references.
Item 1042-A, 1042-B (MF)
Distributed to some depository libraries in microfiche.
Shipping list no.: 92-0400-P.
"Serial no. J-102-48."